California-based online vaccination planner MyTurn COVID-19 has agreed to state policy adopted last week and is now ordering boosters for adults without asking them to declare they are age, health, occupation, or living criteria that would expose them to more at risk from the virus.
Visitors to MyTurn.CA.gov can simply declare that they are 18 years of age or older and at least six months after their last dose of Pfizer or Moderna, or two months after a Johnson & Johnson vaccination, to schedule a booster shot.
California last week became the first of several states and local governments to make booster vaccinations eligible for those who received the most common vaccines from Pfizer and Moderna, in addition to the US Centers for Disease Control and Prevention risk criteria. Santa Clara County also expanded its eligibility criteria last week and quickly reflected changes on the Internet.
But a week after the state sent out booster policy change notices, MyTurn still required those who had Pfizer or Moderna who wanted to make follow-up appointments to declare they were high-risk.
The CDC currently states that boosters vaccinated with Pfizer or Moderna six months or more ago need boosters only if they are 65 or older or 18 or older and either have underlying medical conditions, work or live in high-risk conditions, including long-term care. …
While state officials have argued that all adults can reasonably claim they are at high risk – California is in the CDC’s high risk category for transmitting the virus – many people who clearly did not meet CDC criteria were embarrassed to state this.
However, major national pharmacies such as Rite Aid and CVS still require those who make online appointments to declare that they meet CDC eligibility criteria. The stores said they, as participants in the federal pharmacy program, are required to follow CDC guidelines.
However, these rules may change soon. The FDA is reviewing Pfizer’s request for a vaccine for all adults, not just those at higher risk, citing evidence of reduced protection after six months. Moderna is also seeking approval. The CDC’s vaccine expert advisory group is meeting Friday and is expected to address the matter.